Gracey Craig sold $24K of OMDA
Gracey Craig (Chief Accounting Officer) sold 1,042 shares of Omada Health, Inc. (OMDA) at an average of $22.61 ($22.00–$23.00) across 2 trades over 2026-06-30 to 2026-07-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider activity but does not provide new operational, financial, or regulatory information about Omada.
Market read
Traders may note the insider sale for sentiment monitoring, but the 10b5-1 structure and small dollar amount limit trading impact.
What to watch
The filing does not disclose reasons for the sale, and the transaction size is modest, reducing the likelihood of a durable signal.
Background
The article is an SEC Form 4 insider transaction disclosure for Omada Health, Inc.
Ticker impact
Omada Health CFO Gracey Craig sold $23,561 of OMDA shares via a 10b5-1 plan on June 30 to July 1 at $22 to $23.
Likely minimal immediate price impact; any effect is more sentiment-driven than fundamental.
The filing is a Form 4 insider transaction, but it is explicitly tied to a pre-arranged 10b5-1 plan and the disclosed value is relatively small versus typical market-moving thresholds.
Market effects
No clear sector read-through from a single, small 10b5-1 insider sale.
None.
None.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.
Key entities
- issuerOmada Health, Inc.
Company whose shares were sold by an officer under a 10b5-1 plan.
- insiderGracey Craig
Chief Accounting Officer who executed the open-market sale.
